All Clinical Trials

Clinical Trial

AALL1631: International Phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones

  • Recruiting participants (Starts Oct. 2, 2017)
  • Not accepting healthy volunteers
  • UTSW Principal Investigator: Tamra Lynn Slone

summary

This randomized phase III trial studies how well imatinib mesylate and combination chemotherapy work in treating patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia.

If you are interested in this clinical trial, please contact Anil Shalwani on the Children’s Health Research Team.Call 214-456-7353Email